MRL VENTURES FUND

mrl-ventures-fund-logo

The MRL Venture Fund is the Cambridge, MA โ€“ based independent venture capital investment group within Merck Research Laboratories, the R&D division of Merck & Co., Inc. MRL Ventures creates and/or invests in seed and early-stage therapeutics companies, based on translatable breakthrough science, with the potential to deliver highly differentiated new medicines to improve human health.

#SimilarOrganizations #People #Financial #More

MRL VENTURES FUND

Industry:
Biotechnology Health Care

Founded:
2014-01-01

Status:
Active

Total Funding:
16 M EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Nginx Amazon DMARC Amazon SSL Amazon CloudFront AWS Global Accelerator ATT DNS


Similar Organizations

aeovian-pharmaceuticals-logo

Aeovian Pharmaceuticals

Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.

amoon-fund-logo

aMoon Fund

aMoon is a leading healthtech & life sciences venture capital firm.

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

levianix-llc-logo

Levianix LLC

Levianix, an alternative asset management fund, serves as a private-sector bailout of the mental and behavioral healthcare industry.

mars-discovery-district-logo

MaRS Discovery District

MaRS is a non-profit organization that partners with entrepreneurs, researchers, business and government.

metis-therapeutics-logo

METiS Therapeutics

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.

morganfranklin-consulting-logo

MorganFranklin Consulting

MorganFranklin is a strategy and execution-focused business consulting firm and professional advisor.

ocugen-logo

Ocugen

Ocugen is a clinical stage biopharmaceutical company.

smartpharm-therapeutics-logo

SmartPharm Therapeutics

SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company.

sorrento-therapeutics-logo

Sorrento Therapeutics

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.


Current Advisors List

roger-perlmutter_image

Roger Perlmutter EVP, Merck Research Labs @ MRL Ventures Fund
Board_member

Current Employees Featured

reza-halse_image

Reza Halse
Reza Halse Partner @ MRL Ventures Fund
Partner
2017-01-01

christine-brennan_image

Christine Brennan
Christine Brennan Partner @ MRL Ventures Fund
Partner
2017-06-01

peter-dudek_image

Peter Dudek
Peter Dudek Partner @ MRL Ventures Fund
Partner

Founder


peter-dudek_image

Peter Dudek

Investments List

Date Company Article Money raised
2022-09-08 Photys Therapeutics MRL Ventures Fund investment in Series A - Photys Therapeutics 75 M USD
2022-08-25 Aktis Oncology MRL Ventures Fund investment in Series A - Aktis Oncology 84 M USD
2022-03-23 LifeMine Therapeutics MRL Ventures Fund investment in Series C - LifeMine Therapeutics 175 M USD
2022-02-22 Eyebiotech MRL Ventures Fund investment in Series A - Eyebiotech 65 M USD
2022-01-06 AmbAgon Therapeutics MRL Ventures Fund investment in Series A - AmbAgon Therapeutics 85 M USD
2021-10-26 Mozart Therapeutics MRL Ventures Fund investment in Series A - Mozart Therapeutics 55 M USD
2021-07-15 PAQ Therapeutics MRL Ventures Fund investment in Series A - PAQ Therapeutics 30 M USD
2021-05-10 Therini Bio MRL Ventures Fund investment in Seed Round - Therini Bio 17 M USD
2021-03-31 Entrada Therapeutics MRL Ventures Fund investment in Series B - Entrada Therapeutics 116 M USD
2021-03-01 Carisma Therapeutics MRL Ventures Fund investment in Series B - Carisma Therapeutics 12 M USD

More informations about "MRL Ventures Fund"

MRL Ventures Fund - Crunchbase Investor Profile

The MRL Venture Fund is the Cambridge, MA โ€“ based independent venture capital investment group within Merck Research Laboratories, the R&D division of Merck & Co., Inc. MRL Ventures creates and/or invests in seed and early โ€ฆSee details»

MRL Ventures Fund - Investments, Portfolio & Company Exits

MRL Ventures is Merckโ€™s independent early-stage therapeutics venture capital fund. New. Resources. ... MRL Ventures Fund has made 11 diversity investments. Their most recent โ€ฆSee details»

MRL Ventures Fund LLC (MRLV) - Life-Sciences-Europe.com

May 23, 2018 MRL Ventures Fund (MRLV) is the therapeutics-focused early-stage corporate venture fund of MSD. MSD is a trade name of Merck & Co., Inc., with headquarters in โ€ฆSee details»

MRL Ventures Fund investment portfolio | PitchBook

MRL Ventures Fund's latest investment was on 30-Oct-2024 in Axonis Therapeutics, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover how our experts ensure youโ€™re getting โ€ฆSee details»

MRL Ventures Fund - Org Chart, Teams, Culture & Jobs - The Org

MRL Ventures Fund (MRLV) invests in innovative therapeutics companies that are developing transformative medicines that have the potential to meaningfully improve the lives of patients. โ€ฆSee details»

MRL Ventures Fund - Funding, Financials, Valuation & Investors

MRL Ventures is Merckโ€™s independent early-stage therapeutics venture capital fund. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. ... How much funding โ€ฆSee details»

MRL Ventures Fund - Massinvestor Venture Capital and Private โ€ฆ

MRL Ventures Fund is a corporate venture fund for Merck, and is actively developing a portfolio of early-stage therapeutic companies, which are focused on delivering innovative therapies to โ€ฆSee details»

MRL Ventures Fund: Performance - PitchBook

MRL Ventures Fund is an early-stage venture capital fund managed by MRL Ventures Fund. The fund is located in Cambridge, Massachusetts. The fund targets the healthcare sector.See details»

MRL Ventures Fund - Investor in Cambridge, Massachusetts - Ask โ€ฆ

The MRL Ventures Fund (MRLV) team invests globally in early-stage, preclinical therapeutics companies to transform patient care. The MRL Ventures Fund (MRLV) is the corporate โ€ฆSee details»

MRL Ventures Fund - teaserclub.com

The MRL Venture Fund is the Cambridge, MA โ€“ based independent venture capital investment group within Merck Research Laboratories, the R&D division of Merck & Co., Inc. MRL โ€ฆSee details»

MRL Ventures Fund - venturecapitalarchive.com

The MRL Ventures Fund (MRLV) is the corporate venture arm of Merck & Co., Inc., located in Cambridge, MA. The MRLV team, comprising experienced lifesciences venture Capital โ€ฆSee details»

MRL Ventures Fund โ€“ Investors Database - Unicorn Nest

The fund is generally included in 2-6 deals every year. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Comparing to the other companies, this MRL โ€ฆSee details»

MRL Ventures Fund - vcinvestorlist.com

MRL Ventures is Merckโ€™s independent early-stage therapeutics venture capital fund. Number of Investments: 46 Number of Exits: 13 Investment Industries: Biotechnology;Health Care โ€ฆSee details»

MRL Ventures Fund - SPEEDA Edge

MRL Ventures Fund (MRLV) is the therapeutics-focused corporate venture fund of Merck & Co., Inc., headquartered in Cambridge, Massachusetts. The fund invests globally in early-stage โ€ฆSee details»

MRL Ventures Fund Investor Information - Funding, Portfolio โ€ฆ

MRL Ventures Fund LLC, based in Delaware, invests in early-stage companies, particularly at the Series A level, with check sizes ranging from $500,000 to $10,000,000. Concentrating on the โ€ฆSee details»

Welcome to Startup Virginia - Startup Virginia

We are the regionโ€™s only non-profit organization serving startup founders, entrepreneurs, and innovators at any ... fund, and grow their businesses. $406M. Revenue Earned. $272M. โ€ฆSee details»

MRL Ventures Fund - Contacts, Employees, Board Members

MRL Ventures is Merckโ€™s independent early-stage therapeutics venture capital fund. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. ... MRL โ€ฆSee details»

Corporate Venturing - Harvard Business Review

So in 2001 the company launched a corporate venture-capital fund in order to engage with cutting-edge biotech firms when they were just start-ups. By 2013, Lilly Ventures had been โ€ฆSee details»

Fortuna Future Ventures: Funding the Next Trillion-Dollar โ€ฆ

18 hours ago United States, March 26, 2025-- Fortuna Future Ventures is launching a venture fund and is looking for investors to be a part of it. The fund aims to help early-stage companies โ€ฆSee details»

Meet the 2025 Access Ventures Fellows โ€” Access Ventures

2 days ago In 2025, the organization will serve nearly 3,000 people experiencing homelessness across 30 cities in California. This summer, Zac will graduate with a masterโ€™s in urban planning โ€ฆSee details»

linkstock.net © 2022. All rights reserved